$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
康奈非尼+比美替尼有效改善黑色素瘤总生存期
2025-10-19 11:44:20
Check Details
治疗黑色素瘤的新选择-比美替尼
2025-10-19 11:44:20
Check Details
恩考芬尼+贝美替尼于黑色素瘤联合治疗取得“空前优势”
2025-10-19 11:44:20
Check Details
恩考芬尼贵吗?济南本地哪里可以购买到?
2025-10-19 11:44:20
Check Details
Darovasertib/克唑替尼治疗预处理的转移性葡萄膜黑色素瘤效果良好
2025-10-19 11:44:20
Check Details
达拉非尼+曲美替尼:双靶获益明确,一线数据瞩目
2025-10-19 11:44:20
Check Details
使用曲美替尼你必须要了解的事情
2025-10-19 11:44:20
Check Details
国内已上市BRAF抑制剂:威罗非尼
2025-10-19 11:44:20
Check Details
威罗非尼适用于什么疾病?用法用量及副作用有哪些?
2025-10-19 11:44:20
Check Details
多食用富含膳食纤维的食物,有助于改善黑色素瘤的免疫治疗反应
2025-10-19 11:44:20
Check Details
达拉非尼也可用于治疗朗格汉斯组织细胞增生症
2025-10-19 11:44:20
Check Details
“抗癌神药”达拉非尼与威罗非尼联合治疗NSCLC
2025-10-19 11:44:20
Check Details
1
2
...
6749
6750
6751
6752
6753
6754
6755
...
10233
10234
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Post-Enzalutamide mCRPC: HRR/PARP, PSMA Radioligand, and Chemotherapy Sequencing
2
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
3
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
4
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
5
Bedaquiline for Drug-Resistant TB: 24-Week Regimen, Combination Duration, and When to Stop or Extend
6
Acalabrutinib Dosing and Combination Regimens: CLL/SLL, MCL, Safety Adjustments
7
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
8
Bosutinib for Ph+ CML: Indications, Dosing Adjustments, and Hepatic/Renal Safety
9
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
10
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
11
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
12
AZA+VEN+IVO Triplet Therapy for Newly Diagnosed IDH1 AML: High Response Rates and Durable Efficacy